Answers are grounded in this paper and cite their sources.
Fibulin-3 attenuates phosphate-induced osteo-/ chondrogenic transdifferentiation and calcification of VSMCs, effects involving inhibition of oxidative stress. Up-regulation or supplementation of Fibulin-3 may be beneficial in reducing the progression of vascular calcification during hyperphosphatemic conditions such as CKD.
No takes yet. Share an insight, caveat, or question.
Luong et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: